For The Better

One analyst thinks there’s about 50% upside for the electric-car maker’s shares over the next 12 months.

The Canadian cannabis producer reported disappointing quarterly results.

Apple investors latched onto some positive inflation news.

Market downturns don’t affect stocks equally.

The vaccine stock is benefiting from an overall market bounce.

Strong quarterly results and management raising its full-year outlook boosted the stock.

Compared to 2019, Dick’s results are fantastic — and its stock looks cheap.

While this number is concerning, it is not a reason to sell yet.

Though it has yet to fully earn the confidence of investors, the retailer is moving in the right direction.

The company’s current stock slump could conceal a brighter future ahead.

These two companies have gotten quite the haircuts in recent months.

This metric can be a great help for those who are seeking stable, long-term investments.

In times of recession, more people look to take college courses, benefiting this education technology stock.

Believing in electric vehicles back then would have made you very wealthy indeed.

With a low payout ratio and long history of dividend growth, Walgreens may offer the safest dividend above 4% in healthcare.

The consumer is still spending money.

Merck’s market-topping 3% dividend yield isn’t the sole reason to buy shares.

Eli Lilly has especially crushed the S&P 500 index year to date.

Humana is one of the most dominant players in the health insurance industry.

Not all renewable energy stocks are equal.